GMRx2 seeks to determine the effectiveness of a new medication that combines three different blood pressure lowering medications into a single tablet to be taken once a day. The 3 medications are: telmisartan, amlodipine and indapamide. All three of these medications are already prescribed to lower blood pressure and are used either independently or with each other in dual combinations.

To be eligible to participate you must:

  • be aged 18 years old or older
  • have mild to moderately high blood pressure
  • be taking between 0 and 3 blood pressure lowering medications
  • be able to attend Curtin University for 4 -5 trial visits over a 5 month period

There are two separate GMRx2 protocols and the study team will determine the most appropriate project for you dependent upon your average blood pressure, your current treatment and other cardiovascular risk factors.

During the trial participants will receive study drug, the use of a BP monitor and be reimbursed for travel costs.

Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number 2021-0303 [PCT] and 2020-0725 [ACT])

Copyright © CCRE. All Rights Reserved
Centre for Clinical Research and Education
Address: School of Population Health, Curtin University, Bentley WA 6102